FMR1 anticorps (AA 36-279)
Aperçu rapide pour FMR1 anticorps (AA 36-279) (ABIN2721254)
Antigène
Voir toutes FMR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 36-279
-
Attributs du produit
- Homo sapiens fragile X mental retardation 1 (FMR1), transcript variant ISO1
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Human recombinant protein fragment corresponding to amino acids 36-279 of human FMR1(NP_002015) produced in E.coli.
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- WB 1:500~2000, IHC 1:50,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
-
Autre désignation
- FMR1
-
Sujet
- The protein encoded by this gene binds RNA and is associated with polysomes. The encoded protein may be involved in mRNA trafficking from the nucleus to the cytoplasm. A trinucleotide repeat (CGG) in the 5' UTR is normally found at 6-53 copies, but an expansion to 55-230 repeats is the cause of fragile X syndrome. Expansion of the trinucleotide repeat may also cause one form of premature ovarian failure (POF1). Multiple alternatively spliced transcript variants that encode different protein isoforms and which are located in different cellular locations have been described for this gene.
-
Poids moléculaire
- 71 kDa
-
ID gène
- 2332
-
NCBI Accession
- NM_002024
-
HGNC
- 2332
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-